ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 110 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $164,054 | +74.3% | 16,521 | +22.2% | 0.00% | +50.0% |
| Q4 2022 | $94,134 | -58.0% | 13,525 | -75.9% | 0.00% | -66.7% |
| Q2 2022 | $224,000 | -5.5% | 56,082 | +5.4% | 0.01% | 0.0% |
| Q1 2022 | $237,000 | -55.1% | 53,212 | -11.5% | 0.01% | -60.0% |
| Q3 2021 | $528,000 | +322.4% | 60,100 | +228.8% | 0.02% | +200.0% |
| Q4 2020 | $125,000 | +150.0% | 18,277 | +51.4% | 0.01% | +66.7% |
| Q2 2020 | $50,000 | +78.6% | 12,075 | +5.0% | 0.00% | +50.0% |
| Q1 2020 | $28,000 | -97.7% | 11,500 | -91.6% | 0.00% | -98.3% |
| Q1 2019 | $1,235,000 | +644.0% | 136,800 | +585.6% | 0.12% | +400.0% |
| Q4 2018 | $166,000 | – | 19,952 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |